The 6-hydroxydopamine model and parkinsonian pathophysiology: Novel findings in an older model

被引:126
作者
Hernandez-Baltazar, D. [1 ,2 ,3 ]
Zavala-Flores, L. M. [4 ]
Villanueva-Olivo, A. [5 ]
机构
[1] CONACyT, Mexico City, DF, Mexico
[2] Desarrollo Cient CONACyT, Mexico City, DF, Mexico
[3] Univ Veracruzana, Inst Neuroetol, Xalapa, Veracruz, Mexico
[4] IMSS, Ctr Invest Biomed Noreste, Monterrey, Nuevo Leon, Mexico
[5] Univ Autonoma Nuevo Leon, Fac Med, Dept Histol, Monterrey, Nuevo Leon, Mexico
来源
NEUROLOGIA | 2017年 / 32卷 / 08期
关键词
Apoptosis; Nigrostriatal; pathway; Neurodegeneration; Substantia nigra; Neuroinflammation; Oxidative stress; VENTRAL TEGMENTAL AREA; SUBSTANTIA-NIGRA; TIME-COURSE; RAT MODEL; INTRASTRIATAL; 6-HYDROXYDOPAMINE; DOPAMINERGIC-NEURONS; CELL-DEATH; PROGRESSIVE DEGENERATION; INDUCED APOPTOSIS; TERMINAL LESIONS;
D O I
10.1016/j.nrl.2015.06.011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The neurotoxin 6-hydroxydopamine (6-OHDA) is widely used to induce models of Parkinson's disease (PD). We now know that the model induced by 6-OHDA does not include all PD symptoms, although it does reproduce the main cellular processes involved in PD, such as oxidative stress, neurodegeneration, neuroinflammation, and neuronal death by apoptosis. In this review we analyse the factors affecting the vulnerability of dopaminergic neurons as well as the close relationships between neuroinflannnnation, neurodegeneration, and apoptosis in the 6-OHDA model. Knowledge of the mechanisms involved in neurodegeneration and cell death in this model is the key to identifying potential therapeutic targets for PD. (C) 2014 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:533 / 539
页数:7
相关论文
共 87 条
[1]   Microglia: Scapegoat, Saboteur, or Something Else? [J].
Aguzzi, Adriano ;
Barres, Ben A. ;
Bennett, Mariko L. .
SCIENCE, 2013, 339 (6116) :156-161
[2]   Gene-based Therapies in Parkinson's Disease [J].
Allen, Patricia J. ;
Feigin, Andrew .
NEUROTHERAPEUTICS, 2014, 11 (01) :60-67
[3]  
ALTAR CA, 1986, EUR J PHARMACOL, V131, P199
[4]   COMPLEX DEFICITS ON REACTION-TIME PERFORMANCE FOLLOWING BILATERAL INTRASTRIATAL 6-OHDA INFUSION IN THE RAT [J].
AMALRIC, M ;
MOUKHLES, H ;
NIEOULLON, A ;
DASZUTA, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1995, 7 (05) :972-980
[5]  
[Anonymous], J DRUG TARGET
[6]   6-OHDA generated ROS induces DNA damage and p53-and PUMA-dependent cell death [J].
Bernstein, Alison I. ;
Garrison, Sean P. ;
Zambetti, Gerard P. ;
O'Malley, Karen L. .
MOLECULAR NEURODEGENERATION, 2011, 6
[7]   Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model [J].
Blandini, Fabio ;
Levandis, Giovanna ;
Bazzini, Eleonora ;
Nappi, Giuseppe ;
Armentero, Marie-Therese .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2007, 25 (02) :397-405
[8]   Animal models of Parkinson's disease [J].
Blandini, Fabio ;
Armentero, Marie-Therese .
FEBS JOURNAL, 2012, 279 (07) :1156-1166
[9]   Parkinson's disease: animal models and dopaminergic cell vulnerability [J].
Blesa, Javier ;
Przedborski, Serge .
FRONTIERS IN NEUROANATOMY, 2014, 8
[10]   Classic and New Animal Models of Parkinson's Disease [J].
Blesa, Javier ;
Phani, Sudarshan ;
Jackson-Lewis, Vernice ;
Przedborski, Serge .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,